Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
-
* Corresponding author: Alexander Tenenbaum altenen@sheba.health.gov.il
Cardiovascular Diabetology 2003, 2:4 doi:10.1186/1475-2840-2-4
Accesses
- Last 30 days: 180 accesses
- Last 365 days: 2019 accesses
- All time: 26418 accesses
Cited by
BioMed Central: 8 citations
|
Review
A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease Enrique Z Fisman, Alexander Tenenbaum Cardiovascular Diabetology 2009, 8:38 (20 July 2009) |
|
Original investigation
Alexander Tenenbaum, Valentina Boyko, Enrique Z Fisman, Ilan Goldenberg, Yehuda Adler, Micha S Feinberg, Michael Motro, David Tanne, Joseph Shemesh, Ehud Schwammenthal, Solomon Behar Cardiovascular Diabetology 2008, 7:18 (19 June 2008) |
|
Review
Alexander Tenenbaum, Enrique Z Fisman, Michael Motro, Yehuda Adler Cardiovascular Diabetology 2006, 5:20 (26 September 2006) |
|
Review
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons Alexander Tenenbaum, Michael Motro, Enrique Z Fisman Cardiovascular Diabetology 2005, 4:14 (16 September 2005) |
|
Editorial
Alexander Tenenbaum, Enrique Z Fisman Cardiovascular Diabetology 2004, 3:10 (1 December 2004) |
|
Review
Melvin R Hayden, Suresh C Tyagi Nutrition Journal 2004, 3:4 (10 May 2004) |
|
Original investigation
Alexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, Yehuda Adler, Michal Benderly, Michael Motro, Joseph Shemesh Cardiovascular Diabetology 2003, 2:14 (23 November 2003) |
|
Hypothesis
Enrique Z Fisman, Michael Motro, Alexander Tenenbaum Cardiovascular Diabetology 2003, 2:11 (12 September 2003) |